137 related articles for article (PubMed ID: 9918992)
1. [Ribotypes of strains of Pseudomonas aeruginosa in a patient with cystic fibrosis].
Ferrús MA; Alonso R; Hernández M; Montes RM; Hernández J
Enferm Infecc Microbiol Clin; 1998 Dec; 16(10):461-4. PubMed ID: 9918992
[TBL] [Abstract][Full Text] [Related]
2. Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Ojeniyi B; Petersen US; Høiby N
APMIS; 1993 Feb; 101(2):168-75. PubMed ID: 8098219
[TBL] [Abstract][Full Text] [Related]
3. Poor clinical outcomes associated with a multi-drug resistant clonal strain of Pseudomonas aeruginosa in the Tasmanian cystic fibrosis population.
Bradbury R; Champion A; Reid DW
Respirology; 2008 Nov; 13(6):886-92. PubMed ID: 18811887
[TBL] [Abstract][Full Text] [Related]
4. Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis.
Ferroni A; Guillemot D; Moumile K; Bernede C; Le Bourgeois M; Waernessyckle S; Descamps P; Sermet-Gaudelus I; Lenoir G; Berche P; Taddei F
Pediatr Pulmonol; 2009 Aug; 44(8):820-5. PubMed ID: 19598278
[TBL] [Abstract][Full Text] [Related]
5. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of diversity within the genus Pseudomonas in the lungs of cystic fibrosis patients.
Spasenovski T; Carroll MP; Payne MS; Bruce KD
Diagn Microbiol Infect Dis; 2009 Mar; 63(3):261-7. PubMed ID: 19216939
[TBL] [Abstract][Full Text] [Related]
7. AP-PCR typing of Pseudomonas aeruginosa isolated from patients with cystic fibrosis.
Giordano A; Magni A; Graziani C; Sessa R; Quattrucci S; Cipriani P
New Microbiol; 2001 Apr; 24(2):157-63. PubMed ID: 11346299
[TBL] [Abstract][Full Text] [Related]
8. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.
Burns JL; Gibson RL; McNamara S; Yim D; Emerson J; Rosenfeld M; Hiatt P; McCoy K; Castile R; Smith AL; Ramsey BW
J Infect Dis; 2001 Feb; 183(3):444-52. PubMed ID: 11133376
[TBL] [Abstract][Full Text] [Related]
9. Long-term azitromycin treatment of cystic fibrosis patients with chronic Pseudomonas aeruginosa infection; an observational cohort study.
Hansen CR; Pressler T; Koch C; Høiby N
J Cyst Fibros; 2005 Mar; 4(1):35-40. PubMed ID: 15752679
[TBL] [Abstract][Full Text] [Related]
10. Achromobacter xylosoxidans in cystic fibrosis: prevalence and clinical relevance.
De Baets F; Schelstraete P; Van Daele S; Haerynck F; Vaneechoutte M
J Cyst Fibros; 2007 Jan; 6(1):75-8. PubMed ID: 16793350
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of Pseudomonas aeruginosa in a tertiary referral teaching hospital.
Bradbury RS; Champion AC; Reid DW
J Hosp Infect; 2009 Oct; 73(2):151-6. PubMed ID: 19699556
[TBL] [Abstract][Full Text] [Related]
12. Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis.
Hoboth C; Hoffmann R; Eichner A; Henke C; Schmoldt S; Imhof A; Heesemann J; Hogardt M
J Infect Dis; 2009 Jul; 200(1):118-30. PubMed ID: 19459782
[TBL] [Abstract][Full Text] [Related]
13. Rapid single-nucleotide polymorphism-based identification of clonal Pseudomonas aeruginosa isolates from patients with cystic fibrosis by the use of real-time PCR and high-resolution melting curve analysis.
Anuj SN; Whiley DM; Kidd TJ; Ramsay KA; Bell SC; Syrmis MW; Grimwood K; Wainwright CE; Nissen MD; Sloots TP
Clin Microbiol Infect; 2011 Sep; 17(9):1403-8. PubMed ID: 21129101
[TBL] [Abstract][Full Text] [Related]
14. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
[TBL] [Abstract][Full Text] [Related]
15. Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.
Campana S; Taccetti G; Ravenni N; Masi I; Audino S; Sisi B; Repetto T; Döring G; de Martino M
J Cyst Fibros; 2004 Aug; 3(3):159-63. PubMed ID: 15463902
[TBL] [Abstract][Full Text] [Related]
16. Pseudomonas aeruginosa diversity in distinct paediatric patient groups.
Tramper-Stranders GA; van der Ent CK; Wolfs TF; Kimpen JL; Fleer A; Johansen U; Johansen HK; Høiby N
Clin Microbiol Infect; 2008 Oct; 14(10):935-41. PubMed ID: 18752596
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis.
Etherington C; Hall M; Conway S; Peckham D; Denton M
J Antimicrob Chemother; 2008 Feb; 61(2):425-7. PubMed ID: 18156280
[TBL] [Abstract][Full Text] [Related]
18. Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15 years experience.
Hansen CR; Pressler T; Høiby N
J Cyst Fibros; 2008 Nov; 7(6):523-30. PubMed ID: 18693078
[TBL] [Abstract][Full Text] [Related]
19. [Various typing methods of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients].
Hafiane A; Ravaoarinoro M
Med Mal Infect; 2008 May; 38(5):238-47. PubMed ID: 18394837
[TBL] [Abstract][Full Text] [Related]
20. Polymorphonuclear leucocytes consume oxygen in sputum from chronic Pseudomonas aeruginosa pneumonia in cystic fibrosis.
Kolpen M; Hansen CR; Bjarnsholt T; Moser C; Christensen LD; van Gennip M; Ciofu O; Mandsberg L; Kharazmi A; Döring G; Givskov M; Høiby N; Jensen PØ
Thorax; 2010 Jan; 65(1):57-62. PubMed ID: 19846469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
